Published in Lancet Oncol on March 13, 2013
The genomic landscape of retinoblastoma: a review. Clin Experiment Ophthalmol (2013) 1.81
Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet (2015) 1.47
EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression. PLoS One (2014) 1.39
RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget (2014) 0.96
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature (2016) 0.96
Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol (2014) 0.95
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol (2014) 0.91
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine (2015) 0.90
MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation. Oncotarget (2015) 0.86
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development. PLoS One (2014) 0.86
Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma. Mol Vis (2015) 0.85
Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma. Lab Invest (2015) 0.84
STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters. Oncotarget (2014) 0.83
Re-characterization of established human retinoblastoma cell lines. Histochem Cell Biol (2014) 0.82
Cancer genetics education in a low- to middle-income country: evaluation of an interactive workshop for clinicians in Kenya. PLoS One (2015) 0.81
Role of MYCN in retinoblastoma. Lancet Oncol (2013) 0.79
Integrin-linked kinase regulates senescence in an Rb-dependent manner in cancer cell lines. Cell Cycle (2015) 0.79
Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala. Cancer Lett (2014) 0.78
Sporadic Retinoblastoma and Parental Smoking and Alcohol Consumption before and after Conception: A Report from the Children's Oncology Group. PLoS One (2016) 0.78
Retinoblastoma genetics in India: From research to implementation. Indian J Ophthalmol (2015) 0.78
Blocking the maturation of OncomiRNAs using pri-miRNA-17∼92 aptamer in retinoblastoma. Nucleic Acid Ther (2014) 0.78
Screening of RB1 gene mutations in Chinese patients with retinoblastoma and preliminary exploration of genotype-phenotype correlations. Mol Vis (2014) 0.77
Retinoblastoma Progression. EBioMedicine (2015) 0.77
A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients. J Hum Genet (2015) 0.77
RB-loss puts focus on Myc. Nat Cell Biol (2015) 0.77
Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation. PLoS One (2015) 0.77
Genetic screening in patients with Retinoblastoma in Israel. Fam Cancer (2015) 0.76
Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep (2016) 0.76
Histopathologic grading of anaplasia in retinoblastoma. Am J Ophthalmol (2014) 0.76
Coregulation of FANCA and BRCA1 in human cells. Springerplus (2014) 0.76
Genetic perspective of retinoblastoma: From present to future. Indian J Ophthalmol (2016) 0.75
Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features. PLoS One (2015) 0.75
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence. J Clin Invest (2017) 0.75
MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene (2016) 0.75
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. Cancer Genet (2016) 0.75
Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology. Int J Mol Sci (2016) 0.75
A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression. PLoS One (2016) 0.75
Retinoblastoma: A new challenge to the Knudson's Dogma. Saudi J Ophthalmol (2013) 0.75
Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med (2017) 0.75
The MYCN Protein in Health and Disease. Genes (Basel) (2017) 0.75
Adding another piece to the retinoblastoma puzzle. Cell Death Dis (2015) 0.75
Defining a new vision for the retinoblastoma gene: report from the 3rd International Rb Meeting. Cell Div (2013) 0.75
Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PLoS One (2017) 0.75
Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: A potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions. PLoS One (2017) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61
A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet (2004) 7.68
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet (2002) 6.29
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet (2006) 4.98
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol (2011) 3.75
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics (2011) 3.68
Resolving the resolution of array CGH. Genomics (2007) 3.66
PIK3CA mutations and copy number gains in human lung cancers. Cancer Res (2008) 3.42
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet (2008) 3.41
Using expression profiling data to identify human microRNA targets. Nat Methods (2007) 3.37
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst (2008) 3.13
Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature (2012) 3.13
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Retinoblastoma. Lancet (2012) 2.98
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One (2009) 2.79
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74
Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res (2007) 2.74
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res (2006) 2.50
Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics (2006) 2.50
Multiple microalterations detected at high frequency in oral cancer. Cancer Res (2005) 2.47
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest (2009) 2.43
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Human cancer long non-coding RNA transcriptomes. PLoS One (2011) 2.38
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest (2010) 2.38
Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol (2011) 2.33
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer (2006) 2.16
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res (2012) 2.10
Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol (2007) 2.10
A stepwise framework for the normalization of array CGH data. BMC Bioinformatics (2005) 2.08
SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics (2004) 2.04
Different aspects of visual impairment as risk factors for falls and fractures in older men and women. J Bone Miner Res (2004) 2.04
The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Invest Ophthalmol Vis Sci (2011) 2.03
Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol (2005) 2.02
Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res (2006) 2.02
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet (2008) 1.98
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. Nat Chem Biol (2011) 1.98
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One (2009) 1.94
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst (2010) 1.92
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89
The genomic landscape of retinoblastoma: a review. Clin Experiment Ophthalmol (2013) 1.81
Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. Cancer Res (2012) 1.78
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res (2010) 1.77
Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma. Arch Ophthalmol (2003) 1.75
3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res (2002) 1.75
One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer (2007) 1.74
EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation. J Thorac Oncol (2013) 1.72
Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A (2010) 1.71
Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol (2010) 1.70
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer (2008) 1.66
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol (2010) 1.66
Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res (2006) 1.65
DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat (2010) 1.65
Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods (2013) 1.64
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene (2005) 1.64
The human retinoblastoma gene is imprinted. PLoS Genet (2009) 1.63
Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol Opt (2004) 1.62
Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet (2006) 1.61
Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation. Hum Genet (2011) 1.60
Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care (2002) 1.60
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg (2014) 1.59
Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer (2006) 1.59
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis. J Mol Diagn (2011) 1.57
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2006) 1.56
A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology (2004) 1.54
Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res (2013) 1.54
Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis. Exp Neurol (2005) 1.53
Modeling recurrent DNA copy number alterations in array CGH data. Bioinformatics (2007) 1.52
Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene (2003) 1.52
Intraoperative ultrasound of the liver in primary and secondary hepatic malignancies: comparison with preoperative 1.5-T MRI and 64-MDCT. AJR Am J Roentgenol (2011) 1.51
Shake, rattle, 'n' roll: the representation of motion in language and cognition. Cognition (2002) 1.50
Genetic alteration and gene expression modulation during cancer progression. Mol Cancer (2004) 1.50
Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics (2007) 1.50
Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. Cancer Res (2011) 1.50
MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. Int J Cancer (2009) 1.48
RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle (2011) 1.47
Chemoreduction for retinoblastoma. Arch Ophthalmol (2003) 1.46
NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics (2012) 1.45
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma. Gynecol Oncol (2004) 1.45
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair. Clin Cancer Res (2013) 1.45
Intravenous fluid infusion rate in microsurgical breast reconstruction: important lessons learned from 354 free flaps. Plast Reconstr Surg (2011) 1.45